References
- Woolf S. Evidence-based medicine: a historical and international overview. Proc. R. Coll. Physicians Edinb. 31(Suppl. 9), 39–41 (2001).
- Marshall JK. A critical approach to clinical practice guidelines. Can. J. Gastroenterol. 14, 505–509 (2000).
- Silagy CA, Stead LF, Lancaster T. Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. Br. Med. J. 323, 833–836 (2001).
- Shekelle PG, Woolf SH, Eccles M et al. Developing guidelines. Br. Med. J. 318, 593–596 (1999).
- Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281, 1900–1905 (1999).
- Goldman HH, Ganju V, Drake RE et al. Policy implications for implementing evidence-based practices. Psychiatric Serv. 52, 1591–1597 (2001).
- Agency for Healthcare Policy and Research, HHS. Invitation to submit guidelines to the National Guideline ClearinghouseTM. Fed. Regist. 63, 18027 (1998).
- Woolf SH, Grol R, Hutchison A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms or clinical guidelines. Br. Med. J. 318, 527–530 (1999).
- The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual. Saf. Health Care 12, 18–23 (2003).
- Institute of Medicine. In: Clinical Practice Guidelines: directions for a New Program. Field MJ, Lohr KN (Eds). National Academy Press, DC, USA (1990).
- Rycroft-Malone J. Formal consensus: the development of a national clinical guideline. Qual. Health Care 10, 238–244 (2001).
- Coleman P, Nicholl J. Influence of evidence-based guidance on health policy and clinical practice in England. Qual. Health Care 10, 229–237 (2001).
- Woolf SH. Evidence-based medicine and practice guidelines: an overview. Cancer Control 7, 362–367 (2000).
- Cranney A, Waldegger L, Graham ID, Man-Son-Hing M, Byszewski A, Ooi DS. Systematic assessment of the quality of osteoporosis guidelines. BMC Musculoskelet. Disord. 3, 20 (2002).
- Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287, 612–617 (2002).
- Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in great Britain: variation in content and implications for treatment. Br. Med. J. 316, 509–513 (1998).
- Unwin N, Thomson R, O’Bryne AM, Laker M, Armstrong H. Implications of applying widely accepted cholesterol screening and management guidelines of British adult population: cross-sectional study of cardiovascular disease and risk factors. Br. Med. J. 317, 1125–1130 (1998).
- Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 355, 103–106 (2000).
- Graham ID, Beardall S, Carter AO et al. What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ 165, 157–163 (2001).
- Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE. Development and application of a generic methodology to assess the quality of clinical guidelines. Int. J. Qual. Health Care 11, 21–28 (1999).
- Pilote L, Tager IB. Outcomes research in the development and evaluation of practice guidelines. BMC Health Serv. Res. 2, 7 (2002).
Websites
- Broughton R, Rathbone B. What makes a good clinical guideline? May 2003. www.evidence-based-medicine.co.uk
- The AGREE Collaboration. AGREE instrument. September 2001. www.agreecollaboration.org/instrument/